Ross M. Kedl, PhD Ask a Question Refer Patient Ross M. Kedl, PhD, is a researcher at National Jewish Health. Dr. Kedl is in the Department of Biomedical Research. Associate Professor Department of Biomedical Research 5280 Top Doctors 2019 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2018-2019 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2019 — Castle Connolly Medical, Ltd. Email Profile Print Profile × No Rating Available In order to provide the most accurate and useful information on our providers, we only post satisfaction data when a provider has received a minimum of 30 survey responses. We have not yet received the minimum number of surveys for this provider, or this provider is a researcher who only sees a limited number of patients in clinic. To learn more about this survey, visit our about the Press Ganey Survey page. Close Overview Contact Info & Locations Research Areas Basic Immunology Cancer Innate Immunity Special Interests Research Interests Innate Immunity and Cancer Immunology The laboratory is investigating how Toll Like Receptors (TLRs) generate innate immunity and how the nature of the innate response effects the generation of downstream adaptive immunity. Much effort has gone into determining the minimal requirements and molecular pathways involved in creating the appropriate immunogenic context of antigen presentation. Since the time of Jenner (Edward, not Bruce) it has been recognized that the presentation of antigens in the context of a microbial or viral infection is potently immunogenic. It was later observed that this immunogenic activity can often be localized to the infectious material itself rather than the process of infection, eg. complete Freunds adjuvant and Coley’s toxin. We now know that a good deal of this immunogenic activity is due to various microbial and viral products interacting with a family of mammalian molecules called Toll-like receptors (TLR) expressed predominantly on cells of the innate immune system. The involvement of TLRs in immunity is at least two fold, first as direct activators of innate immunity and second as initiators of adaptive immunity. TLR stimulation induces immediate innate effector functions and also creates the necessary conditions for the initiation of adaptive immunity. A dual role of TLRs in both innate and adaptive immunity has been confirmed in mice with genetic deletions of TLRs or TLR signaling molecules. Generally, mice with such deletions induce innate immunity less efficiently and have lower T and B cell responses to infection or vaccination than their wild type littermates. Education Education 1993 - 1997 University of Minnesota Medical School (Minneapolis, MN), PhD, Pathobiology 1988 - 1992 College of Biological Science, University of Minnesota (St. Paul, MN), BS, Biology Fellowship 1997 - 2001 Laboratory of John Kappler and Philippa Marrack, Howard Hughes Medical Institute, National Jewish Health, Professional Memberships AAI Publications Catherine Haluszczak, Adovi D. Akue, Sara E. Hamilton, Lindsey Pujanauski, Lenka Teodorovic, Lisa D.S. Johnson, Stephen C. Jameson, and Ross M. Kedl. The naive antigen-specific CD8+ T cell repertoire contains memory phenotype cells that bear the signature of homeostatic expansion. 2008 206(2):435. Phillip J. Sanchez, Catherine Haluszczak, Hideo Yagita, and Ross M. Kedl. Combined-TLR/CD40 Stimulation Mediates Potent Cellular Immunity by Regulating Dendritic Cell Expression of CD70 In Vivo. 2007 Journal of Immunology, 178:1564-1572. Cory Ahonen, Christie L. Doxsee, Sean McGurran, Tony R. Riter, Randolph J. Noelle and Ross M. Kedl. Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN. 2004 Journal of Experimental Medicine 199: 775–784. Ross M. Kedl, Brian C. Schaefer, John W. Kappler, and Philippa Marrack. T cells down-modulate antigen/MHC complexes on antigen presenting cells in vivo. 2002 Nature Immunology 3(1):27-32. Ross M. Kedl, William A. Rees, David A. Hildeman, Brian Schaefer, John Kappler, and Philippa Marrack. T cells compete for access to antigen bearing antigen presenting cells. Journal of Experimental Medicine, 192(8):1105-1113 2000. Academic Affiliations Faculty Member, University of Colorado Denver Teaching & Professional Positions 2001-2004: Senior Immunologist, 3M Pharmaceuticals, 3M Center, 270-2S-06 (St. Paul, MN) 2002-2004: Adjunct Assistant Professor, University of Minnesota, Department of Lab Medicine and Pathology (Minneapolis, MN) Ask a Question through Patient Portal Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 303.270.2061Fax: 303.270.2325 Email: Ross.email@example.com Locations National Jewish Health Main Campus 1400 Jackson St. Denver, CO 80206 Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.